Articles Tagged With: menopausal
-
Menopausal Hormonal Therapy and Breast Cancer Risk: Are Old Data Relevant to Today’s Practice?
An individual-participant meta-analysis of prospective studies found menopausal hormone therapy associated with an elevation in the risk of breast cancer, with the highest risks associated with daily combined therapy.
-
Consider Vaginal Estrogen for Genitourinary Syndrome of Menopause
-
Understand New Advances in Menopause Management
The Food and Drug Administration recently approved two new modalities to aid in menopause management: MenoCheck, a diagnostic tool to show a woman’s menopausal status, and Bijuva, a medication to help with hot flashes.
-
Hormone Therapy and Mortality: No Overall Effect?
An evaluation of outcomes of users and nonusers of postmenopausal hormonal therapy followed longitudinally in the Danish database showed no overall difference in mortality.
-
Does Childhood Adversity Affect the Menopausal Transition?
The number and timing of adverse childhood experiences in relation to puberty affect the risk of incident major depressive disorder in the menopausal transition.
-
Task Force Recommends Against Hormone Therapy for Chronic Conditions
The U.S. Preventive Services Task Force has issued a final recommendation statement and evidence summary upholding its earlier recommendation against use of hormone therapy for the primary prevention of chronic conditions in postmenopausal women.
-
Hormone Replacement: Have We Made Progress Since WHI?
Vaginal estrogen may improve vaginal symptoms of menopause and does not increase the risk for endometrial cancer, stroke, or cardiovascular disease.
-
Individualized Homeopathy for Moderate to Severe Depression in Menopausal Women
A higher risk of depressive symptoms has been observed in the menopausal transition period. Antidepressant medications are often recommended; however, many meta-analyses have only shown modest benefit of such medications over placebo. This study compares individual homeopathic treatment vs. placebo and the antidepressant medication fluoxetine vs. placebo for the treatment of moderate to severe depression in peri- and postmenopausal women.